Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Comment by Snoinamon Jul 12, 2016 5:52pm
101 Views
Post# 25046236

RE:RE:Long term debt...

RE:RE:Long term debt...I hear where you're coming from but i don't see it that way. There's no need to dilute stock, not anytime soon at least. Nor sell assets. There are enough revenues to cover costs short and mid term without major asset liquidation. There are struggles ahead for sure but sales of individual drugs should keep the wolves at bay. I don't see anything that management shouldn't be able to handle. I realize I'm in the minority to think this way otherwise the stock price would be over $90 but thats where I think its going. If I followed the herd, I'd always be showing up late for the party!!
<< Previous
Bullboard Posts
Next >>